Brennan Daniel J.
- SEC CIK
- 0001595612
No open-market purchases or sales filed in the past year.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.Directoras of Jun 18, 2026
- WAT Waters CorpDirectoras of Feb 27, 2026
- BSX Boston Scientific CorpEVP and CFOas of Feb 19, 2025
- NUAN Nuance Communications, Inc.Directoras of Mar 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Brennan Daniel J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BSX Boston Scientific Corp
EVP and CFO10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing) | Feb 18-19 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −84.9K | $105.10 | −$8.92M | −27.3%225.8K after | 3 lots10b5-1 |
| Feb 13, 2025 (view filing) | Feb 12 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −15.1K | $105.07 | −$1.59M | −5.9%241.5K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Jan 3 | Same day | Brennan Daniel J.EVP and CFO | SSale | −9.69K | $89.86 | −$870.7K | −4.1%223.9K after | 10b5-1 |
| May 23, 2024 (view filing) | May 22-23 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −112.1K | $75.57 | −$8.47M | −33.4%223.9K after | 2 lots10b5-1 |
| Feb 20, 2024 (view filing) | Feb 20 | Same day | Brennan Daniel J.EVP and CFO | SSale | −13.7K | $65.86 | −$899.8K | −4.8%271.5K after | |
| Mar 2, 2023 (view filing) | Mar 1-2 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −105.6K | $46.65 | −$4.93M | −31.9%226.0K after | 2 lots |
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −7.57K | $47.14 | −$356.9K | −2.7%276.3K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Brennan Daniel J.EVP and CFO | SSale | −11.0K | $44.03 | −$485.6K | −4.0%264.3K after | |
| Feb 24, 2022 (view filing) | Feb 22 | 2 days | Brennan Daniel J.EVP and CFO | SSale | −53.2K | $42.75 | −$2.27M | −16.3%272.8K after | |
| Feb 17, 2022 (view filing) | Feb 15-16 | 2 days | Brennan Daniel J.EVP and CFO | SSale | −21.3K | $43.60 | −$929.7K | −7.4%266.2K after | 2 lots |